Trials / Unknown
UnknownNCT00309426
Effect of Fetuin A in Hemodialysis Patients
The Effect of Serum Fetuin A Concentration on the 5-Year Prognosis in Hemodialysis Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (planned)
- Sponsor
- University of Shizuoka · Academic / Other
- Sex
- All
- Age
- 0 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.
Detailed description
Fetuin A is known to be a potent inhibitor of ectopic calcification in plasma, and the concentration of fetuin A is closely associated with protein nutritional status. The purpose of this study is to examine whether the plasma concentration of fetuin A is associated with atherosclerosis and 5-year prognosis in hemodialysis patients.
Conditions
Timeline
- Start date
- 2001-03-01
- Completion
- 2006-03-01
- First posted
- 2006-03-31
- Last updated
- 2006-05-22
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00309426. Inclusion in this directory is not an endorsement.